Humoral immune responses and protective efficacy of sequential B- and T-cell epitopes of v antigen of Yersinia pestis by intranasal immunization in microparticles

Medical Microbiology and Immunology

Volumn 198, Issue 4, 2009, Pages 247-256

  Uppada, Jayaprakash Babu ^a   Khan, Arif Azam ^a   Bhat, Ajaz Ahmad ^a   Deshmukh, Ranjana ^b   Rao, Donthamsetty Nageswara ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^b Haffkine Institute for Training Research and Testing India   (India)

Author keywords

B T construct; Intranasal; Microparticles; Mucosal immunity; Plague; V antigen

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL VACCINE; BACTERIUM ANTIBODY; EPITOPE; IMMUNOGLOBULIN A ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; IMMUNOGLOBULIN G1 ANTIBODY; IMMUNOGLOBULIN G2A ANTIBODY; IMMUNOGLOBULIN G2B ANTIBODY; MICROSPHERE; POLYGLACTIN; SECRETORY V ANTIGEN; UNCLASSIFIED DRUG; YERSINIA PESTIS VACCINE;

ANIMAL EXPERIMENT; ANTIBODY BLOOD LEVEL; ANTIBODY PRODUCTION; ANTIBODY TITER; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; DRUG EFFICACY; DRUG FORMULATION; FEMALE; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOGENICITY; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTECTION; T LYMPHOCYTE; YERSINIA PESTIS; YERSINIOSIS;

ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; EPITOPES, B-LYMPHOCYTE; EPITOPES, T-LYMPHOCYTE; FEMALE; IMMUNITY, HUMORAL; IMMUNOLOGIC MEMORY; LACTIC ACID; MICE; MICE, INBRED BALB C; MICROSPHERES; PLAGUE VACCINE; POLYGLYCOLIC ACID; PORE FORMING CYTOTOXIC PROTEINS; YERSINIA PESTIS;

EID: 70350596217     PISSN: 03008584     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00430-009-0124-7     Document Type: Article

References (46)

1. AK Abbas K Murphy A Sher 1996 A functional diversity of helper T lymphocytes Nature 383 787 793 10.1038/383787a0 1:CAS:528:DyaK28XmsF2qsLY%3D 8893001 (Pubitemid 26372655)
2. R Ahmed D Gray 1996 Immunological memory and protective immunity: understanding their relation Science 272 54 60 10.1126/science.272.5258.54 1:CAS:528:DyaK28XitVKkt7w%3D 8600537
3. AV Philipovskiy C Cowan CR Wulff-Strobel SH Burnett EJ Kerschen DA Cohen AM Kaplan SC Straley 2005 Antibody against V antigen prevents Yop-dependent growth of Yersinia pestis Infect Immun 73 1532 1542 10.1128/IAI.73.3.1532-1542. 2005 1:CAS:528:DC%2BD2MXit12msrY%3D 15731051 (Pubitemid 40470739)
4. GW Anderson PL Worsham CR Bolt GP Andrews SL Welkos AM Friedlander JP Burans 1997 Protection of mice from fatal bubonic and pneumonic plague by passive immunization with monoclonal antibodies against the F1 protein of Yersinia pestis Am J Trop Med Hyg 56 471 473 1:CAS:528:DyaK2sXjsV2qs7o%3D 9158060
5. T Blisnick P Ave M Huerre E Carniel CE Demeure 2008 Oral vaccination against bubonic plague using a live avirulent yersinia pseudotuberculosis strain Infect Immun 76 3808 3816 10.1128/IAI.00034-08 1:CAS:528:DC%2BD1cXptF2hsrY%3D 18505804
6. DJ Cher TR Mosmann 1987 Two types of murine helper T cell clones II. Delayed-type hypersensitivity is mediated by Th1 clones J Immunol 138 3688 3694 1:CAS:528:DyaL2sXkvFGjtb4%3D 2953788
7. GR Cornelis 2002 Yersinia type III secretion: send in the effectors J Cell Biol 158 401 408 10.1083/jcb.200205077 1:CAS:528:DC%2BD38XmtVeksrg%3D 12163464 (Pubitemid 34851697)
8. GR Cornelis A Boland AP Boyd C Geuijen M Iriarte C Neyt MP Sory I Stainier 1998 The virulence plasmid of Yersinia, an antihost genome Microbiol Mol Biol Rev 62 1315 1352 1:CAS:528:DyaK1MXhs1Ontg%3D%3D 9841674
9. CA Cornelius LE Quenee KA Overheim F Koster TL Brasel D Elli NA Ciletti O Schneewind 2008 Immunization with recombinant V10 protects Cynomolgus macques from lethal pneumonic plague Infect Immun 76 5588 5597 10.1128/IAI.00699-08 1:CAS:528:DC%2BD1cXhsVOgs77K 18794281
10. M Croft SL Swain 1991 B cell response to T helper cell subsets. II Both the stage of T cell differentiation and the cytokines secreted determine the extent and nature of helper activity J Immunol 147 3679 3689 1:CAS:528:DyaK38XlslaksA%3D%3D 1682380
11. GL Daniel C Longstaff BA Wallace J Hill SEC Leary W Richard RW Titball KA Brown 2002 Interactions of the type III secretion pathway proteins LcrV and LcrG from Yersinia pestis are mediated by coiled-coil domains J Biol Chem 277 41 38714 38722 10.1074/jbc.M203632200 (Pubitemid 35154733)
12. HJ Dyson PE Wright 1995 Antigenic peptides FASEB J 9 37 42 1:CAS:528:DyaK2MXjt1OmtLg%3D 7821757
13. J Hill SEC Leary KF Griffin ED Williamson RW Titball 1997 Regions of Yersinia pestis V Antigen that contribute to protection against plague identified by passive and active immunization Infect Immun 65 4476 4482 1:CAS:528:DyaK2sXntlSgt7Y%3D 9353022
14. LM Hodge JW Simecka 2002 Role of upper and lower respiratory tract immunity in resistance to Mycoplasma respiratory disease J Infect Dis 186 290 294 10.1086/341280 12134269 (Pubitemid 34765520)
15. J Holmgreen C Czerkinsky 2005 Mucosal immunity and vaccines Nat Med 11 S45 S53 10.1038/nm1213 (Pubitemid 40562303)
16. R Jemmerson 1987 Antigenicity and native structure of globular proteins: low frequency of peptide reactive antibodies Proc Natl Acad Sci USA 84 9180 9184 10.1073/pnas.84.24.9180 1:CAS:528:DyaL1cXhtFSnur4%3D 2447585
17. R Jemmerson R Blankenfeld 1989 Affinity consideration in the design of synthetic vaccines intended to elicit antibodies Mol Immunol 26 301 307 10.1016/0161-5890(89)90084-9 1:CAS:528:DyaL1MXhvFSltrc%3D 2539562 (Pubitemid 19082783)
18. X Jiao T Hirano Y Hou XX Gu 2002 Specific immune responses and enhancement of murine pulmonary clearance of Moraxella catarrhalis by intranasal immunization with a detoxified lipooligosaccharide conjugate vaccine Infect Immun 70 5982 5989 10.1128/IAI.70.11.5982-5989.2002 1:CAS:528: DC%2BD38XotFGks78%3D 12379673 (Pubitemid 35192686)
19. J Pettersson A HolmstroÈm J Hill S Leary E Frithz-Lindsten A von Euler-Matell E Carlsson R Titball A Forsberg H Wolf-Watz 1999 The V-antigen of Yersinia is surface exposed before target cell contact and involved in virulence protein translocation Mol Microbiol 32 5 961 976 10.1046/j.1365-2958.1999. 01408.x 1:CAS:528:DyaK1MXjvVSms7k%3D 10361299 (Pubitemid 29255763)
20. AA Khan JP Babu G Gupta DN Rao 2008 Identifying B and T cell epitopes and studying humoral, mucosal and cellular immune responses of peptides derived from V antigen of Y. pestis Vaccine 26 316 332 10.1016/j.vaccine.2007.11.028 1:CAS:528:DC%2BD1cXivFWmsA%3D%3D 18096277
21. E Maggi P Parronchi R Manetti C Simonelli MP Piccini FS Rugiu M Decarli M Ricci S Romagnani 1992 Reciprocal regulatory effects of IFN-gamma and IL-4 on the in vitro development of human Th1 and Th2 clones J Immunol 148 2142 2147 1:CAS:528:DyaK38XisFekt7o%3D 1532000
22. JS Matson ML Nilles 2001 LcrG-LcrV interaction is required for control of Yops secretion in Yersinia pestis J Bacteriol 183 5082 5091 10.1128/JB.183.17.5082-5091.2001 1:CAS:528:DC%2BD3MXmtFKrs78%3D 11489861 (Pubitemid 32750936)
23. V Mett J Lyons K Musiychuk JA Chichester T Brasil R Couch R Sherwood GA Palmer SJ Streatfield V Yusibov 2007 A plant-produced plague vaccine candidate confers protection to monkeys Vaccine 25 3014 3017 10.1016/j.vaccine.2007.01.017 1:CAS:528:DC%2BD2sXjslSrsrc%3D 17287055 (Pubitemid 46482733)
24. DR Milch 1990 Synthetic peptides: prospects for vaccine development Semin Immunol 2 307 315
25. MA Hamad ML Niles 2007 Structure-function analysis of the C-terminal domain of LcrV from Yersinia pestis J Bacteriol 189 18 6734 6739 10.1128/JB.00539-07 1:CAS:528:DC%2BD2sXhtVKlsrbL 17644582 (Pubitemid 47397382)
26. CA Mueller P Broz SA Muller P Ringler F Erne-Brand I Sorg M Kuhn A Engel GR Cornelis 2005 The V-antigen of Yersinia forms a distinct structure at the tip of injectisomes needle Science 310 674 676 10.1126/science.1118476 1:CAS:528:DC%2BD2MXhtFChsLjM 16254184 (Pubitemid 41528159)
27. NS Nedialkov VL Motin RR Brubaker 1997 Resistance to lipopolysaccharide mediated by the Yersinia pestis V antigen-polyhistidine fusion peptide amplification of interleukin-10 Infect Immunity 65 1196 1203 1:CAS:528:DyaK2sXit12ju74%3D
28. RD Perry JD Fetherston 1997 Yersinia pestis-etiological agent of plague Clin Microb Rev 10 35 66 1:CAS:528:DyaK2sXotlSqtw%3D%3D
29. M Robert-Guroff 2000 IgG surfaces as an important component in mucosal protection Nat Med 6 129 130 10.1038/72206 1:CAS:528:DC%2BD3cXosFyrtg%3D%3D 10655090 (Pubitemid 30082343)
30. P Russell SM Eley SE Hibbs RJ Manchee AJ Stagg RW Titball 1995 A comparison of plague vaccine USP and EV 76 vaccine induced protection against Yersinia pestis in a murine model Vaccine 13 1551 1556 10.1016/0264-410X(95) 00090-N 1:STN:280:DyaK287msVCksg%3D%3D 8578841
31. L Sabhnani DN Rao 2000 Identification of immunodominant epitope of F1 antigen of Yersinia pestis FEMS Immunol Med Microbiol 27 155 162 10.1111/j.1574-695X.2000.tb01426.x 1:CAS:528:DC%2BD3cXltVaqsg%3D%3D 10640611
32. L Sabhnani M Manocha K Sridevi D Shashikiran R Rayanade DN Rao 2003 Developing subunit immunogens using B- and T-cell epitopes and their constructs derived from the F1 antigen of Yersinia pestis using novel delivery vehicles FEMS Immunol Med Microbiol 38 215 229 10.1016/S0928-8244(03)00170-6 1:CAS:528:DC%2BD3sXns12mu7k%3D 14522457 (Pubitemid 37289746)
33. DH Sachs AN Schechter A Eastlake CB Anfinsen 1972 An immunologic approach to the conformational equilibria of polypeptides Proc Natl Acad Sci USA 69 3790 3794 10.1073/pnas.69.12.3790 1:CAS:528:DyaE3sXls1artg%3D%3D 4118873
34. A Sing D Rost N Tvardovskaia A Roggenkamp A Wiedemann CJ Kirschning M Aepfelbacher J Heesemann 2002 Yersinia V-antigen exploits Toll-like receptor 2 and CD 14 for interleukin 10-mediated immunosuppression J Exp Med 196 1017 1024 10.1084/jem.20020908 1:CAS:528:DC%2BD38XotFGltLY%3D 12391013 (Pubitemid 35231760)
35. GM Spiekermann PW Finn ES Ward J Dumont BL Dickinson RS Blumberg WI Lencer 2002 Receptor-mediated immunoglobulin G transport across mucosal barriers in adult life: functional expression of FcRn in the mammalian lung J Exp Med 196 303 310 10.1084/jem.20020400 1:CAS:528:DC%2BD38XmtVOhtL4%3D 12163559 (Pubitemid 34875660)
36. TL Stevens A Bossie VM Sanders R Fernandez-Botran RL Coffman TR Mosmann ES Vitetta 1988 A regulation of antibody isotype secretion by subsets of antigen-specific T cells Nature 334 255 258 10.1038/334255a0 1:CAS:528:DyaL1cXlt1Ojsbw%3D 2456466 (Pubitemid 18173376)
37. V Tripathi KT Chitralekha AR Bakshi D Tomar RA Deshmukh M Baig DN Rao 2006 Inducing systemic and mucosal immune responses to B-T construct of F1 antigen of Yersinia pestis in microsphere delivery Vaccine 24 3279 3289 10.1016/j.vaccine.2006.01.031 1:CAS:528:DC%2BD28XivFSjs70%3D 16476510
38. JE Trosky ADB Liverman K Orth 2008 Yersinia outer proteins: Yops Cell Microbiol 10 557 565 10.1111/j.1462-5822.2007.01109.x 1:CAS:528: DC%2BD1cXisFSmsb0%3D 18081726 (Pubitemid 351194085)
39. Derewenda U, Mateja A, Devedjiev Y, Routzahn KM, Evdokimov AG, Derewenda ZS, Waugh DS (2004) The structure of Yersinia pestis V-Antigen, an essential virulence factor and mediator of immunity against plague structure. 12: 301-306
40. S Weeks J Hill A Friedlander S Welkos 2002 Anti-V antigen antibody protects macrophages from Yersinia pestis-induced cell death and promotes phagocytosis Microb Pathog 32 227 237 10.1006/mpat.2002.0498 1:CAS:528:DC%2BD38XksF2gt7k%3D 12071679 (Pubitemid 34729217)
41. ED Williamson SM Eley KF Griffin M Green P Russell SE Leary PC Oyston T Easterbrook KM Reddin A Robinson 1995 A new improved sub-unit vaccine for plague: the basis of protection FEMS Immunol Med Microbiol 12 223 230 10.1111/j.1574-695X.1995.tb00196.x 1:CAS:528:DyaK28Xhsl2qtQ%3D%3D 8745007
42. ED Williamson SM Eley AJ Stagg M Green P Russell RW Titball 2000 A single dose sub-unit vaccine protects against pneumonic plague Vaccine 19 566 571 10.1016/S0264-410X(00)00159-6 1:CAS:528:DC%2BD3cXntF2rs74%3D 11027822 (Pubitemid 30750743)
43. ED Williamson SM Eley AJ Stagg M Green P Russell RW Titball 1997 A sub-unit vaccine elicits IgG, spleen cell cultures and bronchial washings and protects immunized animals against pneumonic plague Vaccine 15 1079 1084 10.1016/S0264-410X(96)00303-9 1:CAS:528:DyaK2sXlvV2gur0%3D 9269050 (Pubitemid 27357190)
44. ED Williamson HC Flick-Smith C LeButt CA Rowland SM Jones EL Waters RJ Gwyther J Miller PJ Packer M Irving 2005 Human immune response to a plague vaccine comprising recombinant F1 and V antigens Infect Immun 73 3598 3608 10.1128/IAI.73.6.3598-3608.2005 1:CAS:528:DC%2BD2MXkvFCnsLo%3D 15908389 (Pubitemid 40745904)
45. ED Williamson PM Vessey KJ Gillhespy SM Eley M Green RW Titball 1999 An IgG1 titre to the F1 and V antigens correlates with protection against plague in the mouse model Clin Exp Immunol 116 107 113 10.1046/j.1365-2249.1999.00859.x 1:STN:280:DyaK1M3isF2rug%3D%3D 10209513 (Pubitemid 29170012)
46. H Yamanaka T Hoyt X Yang S Golden CM Bosio K Crist T Becker M Maddaloni DW Pascual 2008 A nasal interleukin-12 DNA vaccine coexpressing Yersinia pestis F1-V fusion protein confers protection against pneumonic plague Infect Immun 76 4564 4573 10.1128/IAI.00581-08 1:CAS:528:DC%2BD1cXhtF2jtbvF 18694965